CERS2 and cholangiocarcinoma: To investigate the role of LASS2 in liver cancer progression, 90 liver cancer specimens (the test cohort consists of 60 HCC patients and 30 human CCA patients) were collected and stained using immunohistochemistry (IHC) to assess LASS2 protein expression.